Skip to content

Smartphone Application for Weight Loss

Efficacy of a Mobile Application for Weight Loss in Overweight and Obese Adults: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02417623
Acronym
OBSBIT
Enrollment
76
Registered
2015-04-15
Start date
2015-01-31
Completion date
2017-01-31
Last updated
2015-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

AIM: To assess the efficacy of an intervention that includes the assistance of a weight loss smartphone application targeted to young people aged 18 to 40 years. DESIGN: Randomisedclinical trial. SETTING: Primary Health Care centres (PHCCs) in Catalonia. PARTICIPANTS: Adults aged 18 to 40 years with criteria of obesity or overweight, consulting PHCCs for any reason and who provide written informed consent to participate in the trial. INTERVENTION GROUP will receive a 12-month weight loss programme that implements recommendations of a Clinical Practice Guideline, complemented with a smartphone app designed specifically for this programme. CONTROL GROUP will receive the usual care. The outcome measure will be weight loss at 12 months. EXPECTED RESULTS: The investigators expect a higher weight loss in the intervention group than in control group.

Detailed description

DESIGN: Randomised clinical trial. SETTING: Primary Health Care centres (PHCCs) in Catalonia, Spain. PARTICIPANTS: Adults aged 18 to 40 years with criteria of obesity or overweight, consulting PHCCs for any reason and who provide written informed consent to participate in the trial. INTERVENTION GROUP will receive a 12-month weight loss programme that implements recommendations of a Clinical Practice Guideline, complemented with a smartphone app designed specifically for this programme. CONTROL GROUP will receive the usual care. The outcome measure will be weight loss at 12 months. EXPECTED RESULTS: The investigators expect a higher weight loss in the intervention group than in control group.

Interventions

BEHAVIORALSmartphone Application group

Intervention group will receive a 12-month weight loss programmed that implements recommendations of a Clinical Practice Guideline, complemented with a smartphone app

Sponsors

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Young adults aged 18 to 40 years with overweight or obesity * availability of the patient's clinical history in the primary care centre * access to a smartphone device that meets the app requirements * access to an Internet data connection

Exclusion criteria

* Morbid obesity with BMI\> 40 * Secondary Obesity (eg endocrine pathology) * eating disorders (the patient or any member of the family); * Presence of any significant comorbidity that a specific treatment (type 1 diabetes mellitus, severe mental illness); * pregnant or desire pregnancy in the next 12 months; * To participate in a weight loss program or taking any medication for weight loss in the moment of the recruitment * Take any medication that may influence body weight;

Design outcomes

Primary

MeasureTime frameDescription
Body weight (Kg)12 monthsChange in body weight at 12 months in the experimental group, compared with the control group. At each study visit, anthropometrics will be recorded by a primary care nurse or doctor. Body weight will be measured with the participant dressed in light clothing with shoes off on a calibrated balance.
Body mass index (Kg/m2)12 monthschange in body mass index at 12 months in the experimental group, compared with the control group.. At each study visit, anthropometrics will be recorded by a primary care nurse or doctor. Body weight will be measured with the participant dressed in light clothing with shoes off on a calibrated balance.

Secondary

MeasureTime frameDescription
cholesterol profile (LDL-cholesterol, HDL-Cholesterol, Cholesterol total)12 monthsTo improve the profile of cholesterol.
Physical activity measured with two brief validated questionnaires12 monthsTo increase physical activity at 12 months. Physical activity will be measured with two brief validated questionnaires, administered in the participant's preferred language (Catalan or Spanish).
GPT levels12 monthsTo monitorize GPT levels
blood pressure12 monthsTo improve the blood pressure
glucemic levels12 monthsTo improve the glucose levels

Countries

Spain

Contacts

Primary ContactGemma Flores-Mateo, PhD
gflores@idiapjgol.org+34977778515

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026